CVE-2014-1811

Description

The TCP implementation in Microsoft Windows Vista SP2, Windows Server 2008 SP2 and R2 SP1, Windows 7 SP1, Windows 8, Windows 8.1, Windows Server 2012 Gold and R2, and Windows RT Gold and 8.1 allows remote attackers to cause a denial of service (non-paged pool memory consumption and system hang) via malformed data in the Options field of a TCP header, aka "TCP Denial of Service Vulnerability."

Category

5.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 30.39% Top 5%
Vendor Advisory microsoft.com Vendor Advisory technet.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://docs.microsoft.com/en-us/security-updates/securitybulletins/2014/ms14-031 patch vendor advisory
http://secunia.com/advisories/58525 third party advisory permissions required
http://blogs.technet.com/b/srd/archive/2014/06/10/assessing-risk-for-the-june-2014-security-updates.aspx vendor advisory
http://www.securityfocus.com/bid/67888 third party advisory vdb entry

Frequently Asked Questions

What is the severity of CVE-2014-1811?
CVE-2014-1811 has been scored as a medium severity vulnerability.
How to fix CVE-2014-1811?
To fix CVE-2014-1811, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-1811 being actively exploited in the wild?
It is possible that CVE-2014-1811 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~30% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.